⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3242083 | 0.85 | MAPT (0.39) | — | |
| SCHEMBL263464 | 0.83 | MAPT (0.41) | — | |
| SCHEMBL22129744 | 0.83 | MAPT (0.41) | — | |
| SCHEMBL10855305 | 0.71 | SIGMAR1 (0.43) | — | |
| SCHEMBL6446353 | 0.70 | — | — | |
| SCHEMBL4729082 | 0.70 | — | — | |
| SCHEMBL920378 | 0.67 | IDO1 (0.38) | — | |
| SCHEMBL4310919 | 0.66 | TLR8 (0.38) | — | |
| SCHEMBL8453468 | 0.64 | NQO1 (0.47) | — | |
| SCHEMBL919691 | 0.61 | IDO1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9365485-B2 | Substituted arylcyclopentenes as therapeutic agents | ALLERGAN, INC. (US) | 2016-06-14 | — | — | US | claimed |
| US-20140323510-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ALLERGAN, INC. (US) | 2014-10-30 | — | — | US | claimed |
| US-8722726-B2 | Substituted arylcyclopentenes as therapeutic agents | ALLERGAN, INC. (US) | 2014-05-13 | — | — | US | claimed |
| US-7956051-B2 | Therapeutic amides and related compounds | ALLERGAN, INC. (US) | 2011-06-07 | — | — | US | claimed |
| EP-2247583-A1 | HYDRAZINES IN GLAUCOMA THERAPY | ALLERGAN, INC. (US) | 2010-11-10 | — | — | EP | claimed |
| US-20100137347-A1 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ALLERGAN, INC. (US) | 2010-06-03 | — | — | US | claimed |
| JP-2009535421-A | — | — | 2009-10-01 | — | — | JP | claimed |
| WO-2009094286-A1 | HYDRAZINES IN GLAUCOMA THERAPY | ALLERGAN, INC. (US) | 2009-07-30 | — | — | WO | claimed |
| US-20090192151-A1 | THERAPEUTIC AMIDES AND RELATED COMPOUNDS | ALLERGAN, INC. | 2009-07-30 | — | — | US | claimed |
| US-7491844-B2 | Therapeutic cyclopentane derivatives | ALLERGAN, INC. (US) | 2009-02-17 | — | — | US | claimed |
| EP-2021322-A2 | THERAPEUTIC CYCLOPENTANE DERIVATIVES | Allergan, Inc. (US) | 2009-02-11 | — | — | EP | claimed |
| WO-2007130902-A2 | THERAPEUTIC CYCLOPENTANE DERIVATIVES | ALLERGAN, INC. (US) | 2007-11-15 | — | — | WO | claimed |
| US-20070259836-A1 | THERAPEUTIC CYCLOPENTANE DERIVATIVES | ALLERGAN, INC. | 2007-11-08 | — | — | US | claimed |
| CN-115702174-B | Production of polypropylene with low volatiles | 博里利斯股份公司 | 2024-05-14 | — | — | CN | disclosed |
| EP-3902023-B1 | COMPOSITION CONTAINING ORGANIC SEMICONDUCTOR, SOLUTION FOR FORMING ORGANIC SEMICONDUCTOR LAYER, ORGANIC SEMICONDUCTOR LAYER, AND ORGANIC THIN FILM TRANSISTOR | TOSOH CORP (JP) | 2024-04-24 | — | — | EP | disclosed |
| CN-115315451-B | Catalyst for olefin polymerization, method for producing catalyst for olefin polymerization, and method for producing olefin polymer using catalyst for olefin polymerization | 日本聚丙烯株式会社 | 2023-12-01 | — | — | CN | disclosed |
| EP-0275381-B1 | DYE TRANSFER PROCESS | BASF Aktiengesellschaft (DE) | 1992-03-04 | — | — | EP | disclosed |
| EP-0275381-A2 | Dye transfer process | BASF Aktiengesellschaft (DE) | 1988-07-27 | — | — | EP | disclosed |
| US-4760049-A | Dye transfer | BASF AKTIENGESELLSCHAFT (DE) | 1988-07-26 | — | — | US | disclosed |
| US-4053466-A | ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS, PLATELET AGGREGATION INHIBITORS | KOHJIN CO., LTD. (JA) | 1977-10-11 | — | — | US | disclosed |